REVIVA PHARMACEUTICALS HOLDINGS, INC. short interest in 2025
In 2025, REVIVA PHARMACEUTICALS HOLDINGS, INC.'s disclosed short interest ran from 15.61% of shares outstanding on 15 Jan 2025 to 18.65% on 31 Dec 2025, a change of +3.04 percentage points. The year's high was 32.92% on 31 Oct 2025 and its low 6.10% on 14 Mar 2025, averaging 15.51% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.57 days on 15 Sep 2025. Full history: REVIVA PHARMACEUTICALS HOLDINGS, INC..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 15.61% (15 Jan 2025)
- End of year
- 18.65% (31 Dec 2025)
- Change
- +3.04 pp
- High
- 32.92% (31 Oct 2025)
- Low
- 6.10% (14 Mar 2025)
- Average
- 15.51%
- Highest days to cover
- 14.57 (15 Sep 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 15.61% | 1.62 | |
| 31 Jan 2025 | 15.07% | 3.17 | |
| 14 Feb 2025 | 12.71% | 2.62 | |
| 28 Feb 2025 | 11.33% | 3.02 | |
| 14 Mar 2025 | 6.10% | 3.58 | |
| 31 Mar 2025 | 6.25% | 5.86 | results (8-K) |
| 15 Apr 2025 | 8.16% | 2.86 | 10-K filed |
| 30 Apr 2025 | 7.20% | 7.78 | |
| 15 May 2025 | 6.51% | 8.12 | 10-Q filed, results (8-K) |
| 30 May 2025 | 7.01% | 5.06 | |
| 13 Jun 2025 | 7.37% | 5.27 | |
| 30 Jun 2025 | 7.66% | 1.00 | |
| 15 Jul 2025 | 12.95% | 1.84 | |
| 31 Jul 2025 | 25.57% | 4.27 | |
| 15 Aug 2025 | 17.07% | 4.43 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 19.28% | 7.04 | |
| 15 Sep 2025 | 19.13% | 14.57 | |
| 30 Sep 2025 | 20.38% | 1.22 | |
| 15 Oct 2025 | 32.75% | 1.00 | |
| 31 Oct 2025 | 32.92% | 2.16 | |
| 14 Nov 2025 | 20.05% | 5.43 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 20.12% | 7.93 | |
| 15 Dec 2025 | 22.29% | 4.68 | |
| 31 Dec 2025 | 18.65% | 2.00 |
See also: REVIVA PHARMACEUTICALS HOLDINGS, INC.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.